DeepLook Medical


Developer of imaging visualization software that enhances detection and interpretation of lesions in dense tissue. The company's platform provides real-time, one-click lesion segmentation, measurement and colorized visualization across multiple imaging modalities, and is integrated into partner imaging platforms and workstations. The company has FDA-clearance for its imaging software and holds patents on its shape-recognition and radiomic data methods.

Industries

N/A

Nr. of Employees

small (1-50)


Products

Lesion visualization and segmentation software

Imaging software that overlays segmentation and colorized visualization of suspicious masses onto clinical imaging viewers, providing automated measurement, morphology delineation and radiomic data extraction.


Services

Deployment and licensing of embedded visualization software for radiology workstations and display systems, including integration with partner platforms and reporting systems.

Collaboration with healthcare systems and research organizations to support studies validating imaging performance and clinical utility.

Live demos and onboarding for prospective customers and partners, including event demos (e.g., RSNA) and workstation-based demonstrations.

Expertise Areas

  • Medical imaging visualization
  • Breast imaging and dense tissue imaging
  • Radiomics and imaging biomarker extraction
  • Embedded imaging software integration (workstation/plugin)
  • Show More (4)

Key Technologies

  • Deterministic shape-recognition algorithms
  • Automated lesion segmentation
  • Radiomic feature extraction
  • Color-overlay visualization
  • Show More (5)

News & Updates

Dr. Charlotte Owens appointed as fractional Chief Medical Officer to lead medical strategy and advance precision imaging initiatives.

Demo scheduling and exhibition plans for RSNA event booth demonstrations.

Company and CEO quoted in a Forbes article discussing AI's role in improving mammogram detection and related industry advances.

Distribution and integration agreement to include lesion visualization outputs into structured reporting workflows.

Raised $1.7 million seed financing to support product development, hiring, clinical research, sales expansion, and regulatory protections.

Second patent issued protecting radiomic data and methods to reveal morphology of masses previously obscured in medical imaging.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.